SCHEMBL19937367

SCHEMBL19937367

CCC(CCF)c1ccc(C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
NR1I2 O75469 1/20 0.37
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
CHRNA7 P36544 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ACHE P22303 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22918209 0.83 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL18714383 0.83 ESR1 (0.46) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL3989199 0.82 ADRA2A (0.48) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL27661301 0.79 ESR1 (0.37) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL20083008 0.79 ACHE (0.39) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL19803213 0.78 ADRA2A (0.42) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL18660101 0.78 NR1I2 (0.58) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL19937453 0.77 ALDH1A1 (0.39) ALDH1A1ESR1ESR2NR1I2ADRA2A
SCHEMBL8750490 0.77 NR1I2 (0.43) ALDH1A1LMNASMN1; SMN2ESR1ESR2
SCHEMBL8302875 0.75 TEAD4 (0.48) ALDH1A1SMN1; SMN2ESR1ESR2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290427-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME Melinta Therapeutics, Inc. (US) 2018-03-07 EP disclosed